Literature DB >> 31456861

The Correlation Between Tenosynovitis Pattern on Two-Phase Bone Scintigraphy and Clinical Manifestation in Patients with Suspected Rheumatoid Arthritis.

Hyung Jin Choi1, Soo Jin Lee1, Ji Young Kim2, Yoon-Kyoung Sung3, Yun Young Choi1.   

Abstract

PURPOSE: To investigate the correlation between the tenosynovitis pattern on two-phase bone scintigraphy (2P-BS) and clinical manifestation in patients with suspected rheumatoid arthritis (RA).
METHOD: 2P-BS including technetium-99m-methylene diphosphonate blood pool and bone phase imaging in 402 consecutive patients with clinically suspected RA were retrospectively reviewed. According to 2010 RA Classification Criteria, patients were grouped as RA and non-RA. Visual assessment of all fingers, toes, wrists, and ankles on 2P-BS was performed. Clinical suspected tenosynovitis was evaluated on physical examination. Rheumatoid factor, anti-cyclic citrullinated protein antibody, C-reactive protein, and estimated sedimentation rate were obtained. Radiographic findings were also used to define early and established arthritis.
RESULTS: Tenosynovitis pattern was detected in 12.7% (51/402 patients) on 2P-BS. A total of 94.1% (48/51) were diagnosed as RA vs. 5.9% (3/51) as non-RA. Of the 48 RA patients with positive 2P-BS finding, 85.4% (41/48) had early arthritis and 14.6% (7/48) had established arthritis. On physical examination, tenosynovitis was suspected in 21.9% (88/402). A total of 56.8% (50/88) belonged to the RA group and 43.2% (38/88) to the non-RA group. The tenosynovitis pattern of 2P-BS and physical examination showed statistical difference and moderate agreement. The positive tenosynovitis pattern on 2P-BS represented up to 26.408 of odds ratio which was highest among the RA-associated factors.
CONCLUSION: Tenosynovitis pattern on 2P-BS was more commonly detected in the RA group and was more frequently associated with early arthritis pattern. Therefore, 2P-BS could give additional information for the detection of subclinical tenosynovitis in early or preclinical RA patients.

Entities:  

Keywords:  Bone scintigraphy; MDP; Rheumatoid arthritis; Tenosynovitis

Year:  2019        PMID: 31456861      PMCID: PMC6694343          DOI: 10.1007/s13139-019-00596-9

Source DB:  PubMed          Journal:  Nucl Med Mol Imaging        ISSN: 1869-3474


  34 in total

1.  Scintigraphy of de Quervain's tenosynovitis.

Authors:  W Sopov; M Rozenbaum; I Rosner; D Groshar
Journal:  Nucl Med Commun       Date:  1999-02       Impact factor: 1.690

Review 2.  [Imaging techniques in rheumatology: scintigraphy in rheumatoid arthritis].

Authors:  D Sandrock; M Backhaus; G Burmester; D L Munz
Journal:  Z Rheumatol       Date:  2003-10       Impact factor: 1.372

3.  Finger contractures due to tendon lesions as a mode of presentation of rheumatoid arthritis.

Authors:  B M ANSELL; E G BYWATERS
Journal:  Ann Rheum Dis       Date:  1953-12       Impact factor: 19.103

4.  Interobserver agreement in ultrasonography of the finger and toe joints in rheumatoid arthritis.

Authors:  Marcin Szkudlarek; Michel Court-Payen; Søren Jacobsen; Mette Klarlund; Henrik S Thomsen; Mikkel Østergaard
Journal:  Arthritis Rheum       Date:  2003-04

5.  Magnetic resonance imaging appearance of the hands and feet in patients with early rheumatoid arthritis.

Authors:  Nathalie Boutry; Anne Lardé; Franck Lapègue; Elizabeth Solau-Gervais; René-Marc Flipo; Anne Cotten
Journal:  J Rheumatol       Date:  2003-04       Impact factor: 4.666

Review 6.  Combination therapy with multiple disease-modifying antirheumatic drugs in rheumatoid arthritis: a preventive strategy.

Authors:  T Pincus; J R O'Dell; J M Kremer
Journal:  Ann Intern Med       Date:  1999-11-16       Impact factor: 25.391

7.  Production of cytokines, vascular endothelial growth factor, matrix metalloproteinases, and tissue inhibitor of metalloproteinases 1 by tenosynovium demonstrates its potential for tendon destruction in rheumatoid arthritis.

Authors:  A Jain; J Nanchahal; L Troeberg; P Green; F Brennan
Journal:  Arthritis Rheum       Date:  2001-08

8.  Antibodies against cyclic citrullinated peptide and IgA rheumatoid factor predict the development of rheumatoid arthritis.

Authors:  Solbritt Rantapää-Dahlqvist; Ben A W de Jong; Ewa Berglin; Göran Hallmans; Göran Wadell; Hans Stenlund; Ulf Sundin; Walther J van Venrooij
Journal:  Arthritis Rheum       Date:  2003-10

9.  Influence of disease-modifying therapy on radiographic outcome in inflammatory polyarthritis at five years: results from a large observational inception study.

Authors:  M A S Bukhari; N J Wiles; M Lunt; B J Harrison; D G I Scott; D P M Symmons; A J Silman
Journal:  Arthritis Rheum       Date:  2003-01

Review 10.  Role of biologics in early arthritis.

Authors:  P Emery; Y Seto
Journal:  Clin Exp Rheumatol       Date:  2003 Sep-Oct       Impact factor: 4.473

View more
  4 in total

1.  Clinical utility of F-18 sodium fluoride PET/CT for estimating disease activity in patients with rheumatoid arthritis.

Authors:  Hee Jin Park; Sung Hae Chang; Jeong Won Lee; Sang Mi Lee
Journal:  Quant Imaging Med Surg       Date:  2021-04

2.  Clinical Use of Quantitative Analysis of Bone Scintigraphy to Assess the Involvement of Arthritis Diseases in Patients with Joint Symptoms.

Authors:  Jeong Won Lee; Ki Jin Jung; Sang Mi Lee; Sung Hae Chang
Journal:  Diagnostics (Basel)       Date:  2020-11-24

3.  Clinical utility of quantitative analysis of bone scintigraphy in detecting clinically active joint and high disease activity in patients with rheumatoid arthritis.

Authors:  Jeong Won Lee; Sung Hae Chang; Su Jin Jang; Hee Jin Park; Sang Mi Lee; Ki Jin Jung
Journal:  BMC Med Imaging       Date:  2021-11-23       Impact factor: 1.930

4.  Feasibility of dual-phase 99mTc-MDP SPECT/CT imaging in rheumatoid arthritis evaluation.

Authors:  Yasser G Abdelhafez; Felipe Godinez; Kanika Sood; Rosalie J Hagge; Robert D Boutin; Siba P Raychaudhuri; Ramsey D Badawi; Abhijit J Chaudhari
Journal:  Quant Imaging Med Surg       Date:  2021-06
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.